Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the A Randomized, Two-Armed, Double-Blind, Single-Dose, Cross-Over, Bioequivalence Clinical Trial to Compare Pharmacokinetic Parameters and Safety of Recombinant Human Factor Viii With Fc Fusion Produced by Aryogen Pharmed Company Versus Elocta® (Reference Product) in Previously Treated Patients With Severe Haemophilia A
Shahab Rafieian
Shahab Rafieian

Associate Professor of Thoracic Surgery

Department General Surgery

School of Medicine

Vali Asr Hospital

Tehran University of Medical Sciences

All Documents
4. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)
7. Covid-19 and Spontaneous Pneumothorax: A Survival Analysis, Journal of Cardiothoracic Surgery (2023)
21. Primary Thoracic Gastrinoma Causing Zollinger-Ellison Syndrome, Indian Journal of Thoracic and Cardiovascular Surgery (2021)